<p>Association of atorvastatin with the risk of hepatotoxicity: a pilot prescription sequence symmetry analysis</p>

Abstract

This is the first study conducted in a real-world setting to evaluate the relationship between ATO and hepatotoxicity using the PSSA in a Chinese population. We found a 1.3- to 1.5-fold increase in risk of hepatotoxicity following ATO, with the greater risk occurring within the first 30 days of treatment.